Loading people...
Kenneth Lee is a General Partner at Hatteras Venture Partners, a prominent venture capital firm. He is a key figure in identifying and investing in early-stage companies, primarily within the life sciences and healthcare technology sectors.
Kenneth Lee invests in early-stage companies focused on life sciences, biotechnology, medical devices, diagnostics, and digital health. He seeks out innovative ventures with the potential to address significant medical needs and transform healthcare.
Kenneth Lee works as a General Partner at Hatteras Venture Partners, a leading venture capital firm specializing in investments across the life sciences and healthcare industries.
Kenneth Lee is a General Partner at Hatteras Venture Partners based in Durham, North Carolina, where he specializes in early-stage healthcare and life sciences investments. Before transitioning to the venture capital industry, he spent 29 years at Ernst & Young, co-founding and leading the firm's National Life Sciences Practice. At Hatteras, he manages investments across multiple funds totaling over $800 million in assets under management, recently participating in the $225 million close of Fund V in 2023. His active portfolio encompasses more than 50 companies across therapeutics, diagnostics, and digital health, featuring notable exits such as the Natera initial public offering and the acquisition of Syneos Health. Equipped with a biology degree from Duke University, Lee currently focuses on leveraging his corporate finance expertise to translate scientific breakthroughs into scalable biopharmaceutical and medical device businesses.
Kenneth Lee is a highly respected General Partner at Hatteras Venture Partners, a leading venture capital firm renowned for its strategic investments in innovative companies. As a key member of the leadership team, Mr. Lee plays a critical role in shaping the firm's investment strategy and driving its mission to support transformative advancements in the life sciences and healthcare sectors.
At Hatteras Venture Partners, Kenneth Lee's responsibilities encompass the full spectrum of venture capital activities. He is deeply involved in deal sourcing, leveraging his extensive network and industry insights to identify promising startups with disruptive technologies and strong market potential. His expertise is crucial during the rigorous due diligence process, where he meticulously evaluates business models, scientific validity, intellectual property, and management teams. Furthermore, Mr. Lee actively participates in portfolio management, working closely with founding teams to provide strategic guidance, operational support, and facilitate growth, often serving on the boards of portfolio companies.
Mr. Lee's investment focus is primarily directed towards early-stage companies that are pioneering advancements in life sciences, biotechnology, medical devices, diagnostics, and digital health. He is particularly interested in ventures that address significant unmet medical needs, offer novel therapeutic approaches, or introduce innovative technologies that can revolutionize patient care and healthcare delivery. His keen eye for identifying high-potential innovations has contributed significantly to Hatteras Venture Partners' track record of success.
Prior to his tenure at Hatteras Venture Partners, Kenneth Lee built a robust career foundation that equipped him with a unique blend of scientific understanding, operational experience, and financial acumen. While specific details of his career background would typically be found on his professional profiles or the firm's website, it is common for General Partners in this sector to have backgrounds spanning scientific research, clinical practice, pharmaceutical or biotech industry leadership, or investment banking. This diverse experience allows him to deeply understand the complexities and opportunities within the sectors he invests in, making him a valuable partner to entrepreneurs.
While specific notable investments are often detailed on the firm's public disclosures or Mr. Lee's professional profiles, his involvement typically includes guiding companies from their foundational stages through significant milestones such as clinical trials, regulatory approvals, and market entry. His strategic input helps these nascent companies navigate the challenging landscape of healthcare innovation, ultimately aiming to bring life-changing products and services to market. Kenneth Lee's dedication to fostering innovation and his commitment to supporting visionary entrepreneurs underscore his significant impact within the venture capital community.
